Financial Health Check: Examining Supernus Pharmaceuticals Inc (SUPN)’s Key Ratios

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Supernus Pharmaceuticals Inc (NASDAQ: SUPN) closed the day trading at $28.97 down -2.39% from the previous closing price of $29.68. In other words, the price has decreased by -$2.39 from its previous closing price. On the day, 0.56 million shares were traded. SUPN stock price reached its highest trading level at $30.18 during the session, while it also had its lowest trading level at $28.86.

Ratios:

For a better understanding of SUPN, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.35 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.95. For the most recent quarter (mrq), Quick Ratio is recorded 1.49 and its Current Ratio is at 1.73. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.

Jefferies Upgraded its Hold to Buy on April 13, 2021, whereas the target price for the stock was revised from $25 to $40.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 21 ’24 when Bhatt Padmanabh P. sold 14,491 shares for $35.31 per share. The transaction valued at 511,677 led to the insider holds 8,570 shares of the business.

Bhatt Padmanabh P. sold 400 shares of SUPN for $14,124 on Mar 20 ’24. The Sr. VP of IP, CSO now owns 8,570 shares after completing the transaction at $35.31 per share. On Mar 19 ’24, another insider, Bhatt Padmanabh P., who serves as the Sr. VP of IP, CSO of the company, sold 12,364 shares for $35.31 each. As a result, the insider received 436,573 and left with 8,570 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SUPN now has a Market Capitalization of 1631636736 and an Enterprise Value of 1336995200. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.67 while its Price-to-Book (P/B) ratio in mrq is 1.71. Its current Enterprise Value per Revenue stands at 2.238 whereas that against EBITDA is 14.752.

Stock Price History:

Over the past 52 weeks, SUPN has reached a high of $35.96, while it has fallen to a 52-week low of $21.99. The 50-Day Moving Average of the stock is -8.40%, while the 200-Day Moving Average is calculated to be -0.39%.

Shares Statistics:

Over the past 3-months, SUPN traded about 433.55K shares per day on average, while over the past 10 days, SUPN traded about 543940 shares per day. A total of 54.72M shares are outstanding, with a floating share count of 52.62M. Insiders hold about 4.28% of the company’s shares, while institutions hold 107.09% stake in the company. Shares short for SUPN as of 1714435200 were 4820516 with a Short Ratio of 11.12, compared to 1711584000 on 4822753. Therefore, it implies a Short% of Shares Outstanding of 4820516 and a Short% of Float of 13.370000000000001.

Most Popular